Author: Alphyn Biologics, Inc.

New JDD Research Paper Finds Few Atopic Dermatitis Topicals Treat Full Spectrum of Disease; Alphyn’s Zabalafin Hydrogel Candidate Cited as Potential Multi-Target Option

November 9, 2026

New JDD Research Paper Finds Few Atopic Dermatitis Topicals Treat Full Spectrum of Disease; Alphyn’s Zabalafin Hydrogel Candidate Cited as Potential Multi-Target Option